| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Lumos Diagnostics Holdings Limited (PINK: LDXHF)
LDXHF Technical Analysis
3
| As on 25th Dec 2024 LDXHF STOCK Price closed @ 0.03 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.06 & Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LDXHFSTOCK Price
| Open | 0.03 | Change | Price | % |
| High | 0.03 | 1 Day | 0.01 | 50.00 |
| Low | 0.03 | 1 Week | 0.01 | 50.00 |
| Close | 0.03 | 1 Month | 0.00 | 0.00 |
| Volume | 36364 | 1 Year | 0.01 | 50.00 |
| 52 Week High 0.33 | 52 Week Low 0.01 | ||||
PINK USA Most Active Stocks
| PSWW | 0.00 | % |
| AFFU | 0.00 | % |
| TXGE | 3316.21 | 2.69% |
| GTVH | 0.00 | % |
| CYBL | 0.01 | % |
| APLD | 9.72 | -3.48% |
| DRNK | 0.00 | % |
| RDAR | 0.00 | % |
| HCMC | 0.00 | % |
| TWOH | 0.00 | % |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
| LDXHF Daily Charts |
LDXHF Intraday Charts |
Whats New @ Bazaartrend |
LDXHF Free Analysis |
|
|
LDXHF Important Levels Intraday
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
| RESISTANCE | 0.03 |
LDXHF Forecast July 2025
| 4th UP Forecast | 0.18 |
| 3rd UP Forecast | 0.13 |
| 2nd UP Forecast | 0.1 |
| 1st UP Forecast | 0.07 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.04 |
| 3rd DOWN Forecast | -0.07 |
| 4th DOWN Forecast | -0.12 |
LDXHF Weekly Forecast
| 4th UP Forecast | 0.05 |
| 3rd UP Forecast | 0.04 |
| 2nd UP Forecast | 0.04 |
| 1st UP Forecast | 0.04 |
| 1st DOWN Forecast | 0.02 |
| 2nd DOWN Forecast | 0.02 |
| 3rd DOWN Forecast | 0.02 |
| 4th DOWN Forecast | 0.01 |
LDXHF Forecast2025
| 4th UP Forecast | 0.65 |
| 3rd UP Forecast | 0.45 |
| 2nd UP Forecast | 0.33 |
| 1st UP Forecast | 0.2 |
| 1st DOWN Forecast | -0.14 |
| 2nd DOWN Forecast | -0.27 |
| 3rd DOWN Forecast | -0.39 |
| 4th DOWN Forecast | -0.59 |
Lumos Diagnostics Holdings Limited ( PINK USA Symbol : LDXHF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LDXHF Business Profile
Lumos Diagnostics Holdings Limited operates as an integrated developer and manufacturer of point-of-care (POC) diagnostic tests. The company develops and manufactures proprietary and in-licensed POC diagnostic tests. Its products include FebriDx, a test that differentiates between bacterial and viral respiratory infections; ViraDx, a combined COVID/Influenza test for acute respiratory infections; and CoviDx, an antigen test for COVID-19. The company also engages in the contract research and development services specialized in the innovation, development, commercialization, and manufacturing of point-of-care diagnostic solutions for clinical and consumer applications. It offers its products through distributors primarily in the North American and European markets. The company was founded in 2004 and is headquartered in Melbourne, Australia. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service